Decision-grade preclinical strategy and investor/partner readiness for early-stage biotech.

We turn discoveries into streamlined plans and diligence-ready narratives—so you raise faster, partner smarter, and spend runway where it counts — on the milestones that matter.

Schedule a Consultation

Bridging Science and Success. Enabling Investor Confidence.

We partner with academics, founders, biotech teams, incubators, and tech transfer offices to turn early discoveries into decision-grade development plans and investor/partner-ready materials. With deep scientific expertise and business-savvy execution, we help you move faster from discovery to IND/CTA through capital-efficient, milestone-driven support designed around your next value inflection. When you need extra hands, we embed with your team to drive execution, coordinate CROs and vendors, and keep progress on track.

  • Preclinical Strategy and Execution

  • Portfolio and Indication Strategy

  • Investor & Partner Readiness

  • Fractional Support

Core Services:

What Clients and Leaders Say

  • "Tim was my first PhD student at Temple and played a central role in building the scientific backbone of my laboratory. From day one, he operated like an owner, bringing intellectual independence, rigorous experimental design, and the work ethic required to tackle complex biological problems head on. He has a rare ability to translate mechanistic insight into clear, executable strategy. That is why we continue to collaborate. I trust his scientific judgment, discipline, and ability to bring structure and forward momentum to difficult problems. I recommend BridgeLine without hesitation to biotech teams seeking strategy grounded in real biology and executed with precision."

    —John Elrod, PhD

    Director, Aging + Cardiovascular Discovery Center at Temple University

  • “I worked with Tim day-to-day at Spark Therapeutics. Tim brings energy, action, and a knack for getting things done with a solid decision-making framework. He blends strong scientific acumen with a pragmatism for translating scientific goals into development roadmaps that work for biotechs. If you need support streamlining, making sure you're focused on decision-enabling work, or simply a strategic thought partner, I wouldn't hesitate to work with Tim and BridgeLine.”

    -Jeffrey Alexander, PhD

    Site Head, Lilly Gateway Labs

  • “In my time working with Tim at Spark Therapeutics, he stood out for his ability to quickly identify what mattered most to reduce risk and keep teams focused on the highest-impact work. He translates complex data into clear priorities, crisp recommendations, and actionable next steps. He's highly collaborative and raises the quality of decision-making across functions. I would strongly recommend BridgeLine to any biotech building toward a key inflection point.”

    -Christopher Rilling, PhD

    VP of Science, Parallel Bio

  • “Tim did an excellent job setting up our data room with a clear, logical structure that significantly streamlined investor diligence. The strategic gaps analysis and deep understanding of biotech fundraising gave us more confidence going into investor conversations.”

    -Crystal Jin, PhD

    Co-founder and CEO, Bound Therapeutics

Two people working at a wooden table with open laptops, notebooks, and pens, discussing documents and notes.

How We Work:

We build around decision-grade clarity, fit-for-purpose studies, and milestone-driven timelines. Engagements are right-sized to your stage and budget—with transparent pricing—and when you need extra capacity, we embed to drive execution. The result: an actionable roadmap, crisp milestones, and dependable delivery that de-risks the program, keeps momentum high, and makes every dollar of runway count.

  • Modalities

    • Gene therapy · RNA therapeutics · gene editing · biologics

    What we do

    • Decision-grade preclinical strategy, IND/CTA-enabling roadmaps, and hands-on execution oversight

    • Translational biology: model selection, endpoint strategy, and fit-for-purpose biomarker plans

    • Scientific diligence and competitive positioning: partner-facing strategy, narratives, and materials built to withstand scrutiny

    • Specialized depth in BBB-crossing strategies and ligand-targeted RNA delivery

    Therapeutic experience

    • Rare disease · cardiovascular · metabolic · pulmonary (fibrosis/ILD) · immunology · neuromuscular · CNS

Our expertise:

Book a Consultation

Interested in working together? Connecting is easy.

Schedule a 30-minute intro call using our online booking tool—pick a time that works for you. Prefer email? Reach us at info@bridgelinetranslational.com or use the contact form below, and we’ll get back to you promptly.

A modern conference room with glass walls, four people in business attire seated at a table, a large window with cityscape view, and a wall-mounted screen displaying a presentation.